Asthma is a common diagnosis for pediatric patients, and something frequently managed in the primary care setting. Due to the multitude of factors that affect asthma, obtaining good control of… Click to show full abstract
Asthma is a common diagnosis for pediatric patients, and something frequently managed in the primary care setting. Due to the multitude of factors that affect asthma, obtaining good control of the disease can be difficult. Managing triggers, medications, and adherence are key to maintaining good asthma control and quality of life. The National Heart, Lung, and Blood Advisory Council has released new guidelines and recommendations to help assist in the management of asthma. The expert panel addressed several key areas and made recommendations based on the available data. Areas addressed were the use of intermittent inhaled corticosteroids, the use of long-acting muscarinic antagonist, allergen mitigation, fractional exhaled nitric oxide testing for asthma diagnosis and management, and immune modulation for asthma control. This article summarizes the key recommendations and changes to the guideline. [Pediatr Ann. 2022;51(4):e132-e135.].
               
Click one of the above tabs to view related content.